Nutrien (TSX:NTR) Stock May Be 36% Below Fair Value

Nutrien stock has delivered a 44.5% total return over the past five years, yet the latest checks show a mixed valuation picture, with the intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to meaningful upside compared with the current market price.

• Over five years, Nutrien has returned 44.5%, which signals that long term holders have already seen substantial value created.
• Future cash flow expectations from Nutrien's fertilizer and crop-input operations can support the current price, while any pressure on agricultural margins or capital needs may weigh on what investors are willing to pay.
• On Simply Wall St's broader checks, Nutrien scores 3 out of 6 for value, which points to a mixed picture rather than a clear bargain or clear overvaluation.

The issue now is whether that 36.2% DCF implied discount offers enough margin of safety for investors after the gains Nutrien has already delivered.

Find out why Nutrien's 25.4% return over the last year is lagging behind its peers.

Does Nutrien Look Undervalued on Cash Flow?

The Discounted Cash Flow (DCF) model here uses cash flow projections to estimate what Nutrien may be worth based on its ability to generate cash for shareholders. Nutrien posted latest twelve month free cash flow of about $2.0b, and the model assumes these cash flows keep growing from this base rather than swinging sharply.

On these assumptions, the DCF points to an estimated intrinsic value of around CA$147 per share. Compared with the current market price, that implies Nutrien is trading at roughly a 36.2% discount to this cash flow based estimate. In other words, the market price appears to sit well below what the model suggests the company’s cash generation can justify, even after the gains the stock has already delivered.

Taken together, this Discounted Cash Flow analysis indicates that Nutrien stock currently appears to be undervalued on these assumptions.

Our Discounted Cash Flow (DCF) analysis suggests Nutrien is undervalued by 36.2%. Track this in your watchlist or portfolio, or discover 10 more high quality undervalued stocks.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Nutrien.

Where Does Nutrien Sit on Earnings?

The P/E ratio suits Nutrien because earnings are a key anchor for a mature, cash generative business. Nutrien currently trades on a P/E of about 13.5x, compared with a Chemicals industry average of roughly 21.2x and a peer group average near 12.7x. That means the stock is priced below the broader industry level but very close to similar companies on this earnings measure.

The fair P/E ratio estimated for Nutrien, based on its profile within the sector, is about 12.8x. The current 13.5x multiple sits only slightly above that level, which points to a valuation that lines up reasonably well with what this framework suggests for the stock. For investors, the P/E does not flag a clear discount or a clear premium at current prices.

Overall, Nutrien looks roughly fairly valued on its P/E multiple when compared with both tailored and industry benchmarks.

See what the numbers say about this price — find out in our valuation breakdown.

The Nutrien Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Nutrien sit between the valuation work above and the practical question of what would need to happen next. They outline which combinations of Nutrien's future growth, margins and earnings would support a higher or lower stock price than today. They also turn each single valuation figure into a set of underlying assumptions that you can follow on the Community page to see whether they continue to hold in real time.

One of the top community narratives on Nutrien: 16% undervalued

"Global food demand is structurally supporting long-term fertilizer use, creating sustained demand for essential crop nutrients like potash and nitrogen, Nutrien's core products…"

Read one of the top narratives on Nutrien

Do you think there's more to the story for Nutrien? Head over to our Community to see what others are saying!

The Bottom Line

For Nutrien, the Discounted Cash Flow (DCF) work suggests meaningful upside based on its cash generation, while the P/E comparison says the stock is priced close to where similar companies trade. The broader checks are mixed, so the DCF signal should be treated as one input rather than a stand alone conclusion. What really decides the risk and reward from here is whether Nutrien can sustain the cash flows implied in the intrinsic value estimate without requiring heavier investment or facing persistent margin pressure.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com